Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.65 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.65 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1196043 | 1.00 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL10591110 | 1.00 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL1197330 | 1.00 | SLC1A3 (0.65) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL9885923 | 0.86 | SLC1A3 (0.52) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL2878257 | 0.86 | SLC1A3 (0.52) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL13304410 | 0.84 | SLC1A3 (0.56) | SLC1A3SLC1A2SLC1A1TP53MMP1 | |
| SCHEMBL1085084 | 0.84 | — | — | |
| SCHEMBL466551 | 0.84 | — | — | |
| SCHEMBL15114574 | 0.84 | — | — | |
| SCHEMBL6548114 | 0.84 | SLC1A3 (0.50) | SLC1A3SLC1A2SLC1A1MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739755-A1 | METHODS AND USES RELATING TO THE COMBUSTION OF GASOLINE FUEL COMPOSITIONS IN A DIRECT INJECTION SPARK IGNITION ENGINE | Innospec Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4673520-A1 | COMPOSITION, METHOD AND USE FOR REDUCING EMISSIONS OF A DIESEL ENGINE | Innospec Limited (GB) | 2026-01-07 | — | — | EP | claimed |
| EP-4634340-A1 | COMPOSITION, METHOD AND USE | Innospec Limited (GB) | 2025-10-22 | — | — | EP | claimed |
| US-20250161220-A1 | LYMPHATIC DELIVERY OF NANOPARTICLES TO TREAT NEURODEGENERATIVE, NEUROLOGICAL, AND EYE CONDITIONS | THE CLEVELAND CLINIC FOUNDATION | 2025-05-22 | — | — | US | claimed |
| WO-2025008645-A1 | METHODS AND USES RELATING TO THE COMBUSTION OF GASOLINE FUEL COMPOSITIONS IN A DIRECT INJECTION SPARK IGNITION ENGINE | INNOSPEC LIMITED (GB) | 2025-01-09 | — | — | WO | claimed |
| EP-4479029-A2 | LYMPHATIC DELIVERY OF NANOPARTICLES TO TREAT NEURODEGENERATIVE, NEUROLOGICAL, AND EYE CONDITIONS | The Cleveland Clinic Foundation (US) | 2024-12-25 | — | — | EP | claimed |
| WO-2024180333-A1 | COMPOSITION, METHOD AND USE FOR REDUCING EMISSIONS OF A DIESEL ENGINE | INNOSPEC LIMITED (GB) | 2024-09-06 | — | — | WO | claimed |
| WO-2024126998-A1 | COMPOSITION, METHOD AND USE | INNOSPEC LIMITED (GB) | 2024-06-20 | — | — | WO | claimed |
| US-11872234-B2 | Vareniciline compound and process of manufacture thereof | PAR PHARMACEUTICAL, INC. (US) | 2024-01-16 | — | — | US | claimed |
| US-11779587-B2 | Vareniciline compound and process of manufacture thereof | PAR PHARMACEUTICAL, INC. (US) | 2023-10-10 | — | — | US | claimed |
| US-6398855-B1 | Method for depositing copper or a copper alloy | IMEC VZW (BE) | 2002-06-04 | — | — | US | claimed |
| EP-1022355-A2 | Deposition of copper on an activated surface of a substrate | Imec (Interuniversity Microelectronics Center) VZW (BE) | 2000-07-26 | — | — | EP | claimed |
| EP-1020543-A1 | Deposition of copper on an activated surface of a substrate | INTERUNIVERSITAIR MICRO-ELEKTRONICA CENTRUM VZW (BE) | 2000-07-19 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| EP-0392543-B1 | Process for the resolution of intermediates useful in the preparation of 1,5-benzothiazepines | ZAMBON SPA (IT) | 1997-08-06 | — | — | EP | claimed |
| EP-0257635-B1 | PERMEABLE, POROUS, POLYMERIC MEMBRANE WITH HYDROPHILIC CHARACTER, METHODS FOR PREPARING SAID MEMBRANES, AND THEIR USE | DOW DANMARK A/S (DK) | 1993-03-03 | — | — | EP | claimed |
| EP-0204476-B1 | CONTROLLED RELEASE DELIVERY SYSTEM FOR MACROMOLECULES | INTERNATIONAL MINERALS AND CHEMICAL CORPORATION (US) | 1992-07-15 | — | — | EP | claimed |
| EP-0257635-A2 | Permeable, porous, polymeric membrane with hydrophilic character, methods for preparing said membranes, and their use | DOW DANMARK A/S (DK) | 1988-03-02 | — | — | EP | claimed |
| EP-0058945-B1 | A PROCESS FOR PREPARING AN OPTICALLY ACTIVE D-ALPHA-TOCOPHEROL AND COMPOUNDS FOR ITS PREPARATION | Eisai Co., Ltd. (JP) | 1986-08-13 | — | — | EP | claimed |
| US-4330478-A | Method of oxidizing a polyvalent metal | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1982-05-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779587-B2 | Vareniciline compound and process of manufacture thereof | COMT, CYP2C9, CYP3A7 | SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885 |
| US-11872234-B2 | Vareniciline compound and process of manufacture thereof | COMT, CYP2C9, CYP3A7 | SLC1A3 3942/4885SLC1A2 2622/4885SLC1A1 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.